Residency Showcase Program Listings

Driscoll Children’s Hospital (DCH) is a free-standing, 191-bed, pediatric, not for profit, tertiary care hospital with more than 30 medical and surgical specialties offering care throughout South Texas, including Corpus Christi, the Rio Grande Valley, Victoria, and Laredo. Through the vision and generosity of its founder, Clara Driscoll, Driscoll Children’s Hospital opened in 1953, becoming the first, and remains the only, free-standing children’s hospital in South Texas. In 2020, Driscoll had almost 122,000 patient visits, including almost 28,000 patients seen at South Texas’ first emergency room created exclusively for children.

DCH offers two (2) PGY-1 residency positions annually for applicants with a primary interest in pediatric pharmacy practice.  

** Please note, the 2022-2023 residency year will be the first year of this program.

PGY-1 residents are provided with a variety of required pediatric experiences, including general pediatrics, pediatric intensive care, pediatric hematology/oncology, neonatal intensive care, cystic fibrosis/pulmonology, and speciality pharmacy.  In addition, residents participate in longitudinal experiences in ambulatory care, pharmacy administration, project management, and practice management.  Elective opportunities allow residents to focus on areas of interest.  Available electives include cardiovascular intensive care/cardiology, investigational medications, renal transplant, advanced practice experiences in core rotations, and additional experiences tailored to resident areas of interest.

An optional teaching and learning certificate program is available, and certification in BLS and PALS is provided. Residents qualify for Driscoll Children's Hospital benefits and receive travel and meeting registration reimbursement for the ASHP Midyear Clinical Meeting and annual PPA meeting.  Residents receive an estimated annual stipend of $55,000.

Interested candidates should submit the following items via PhORCAS to the Program Director no later than December 27th, 2021. 

• Letter of Intent – one page letter explaining why the candidate is interested in the position and what qualifications he/she has that are not fully captured within the remaining application packet
• Curriculum vitae
• College transcript(s)
• Three letters of recommendation (including one from an employer or supervisor)

Additional application requirements include: Pharm.D. degree, eligibility for Texas licensure, photograph of applicant, and on-site interview including presentation to preceptors. Applicants must not use any nicotine-containing products.  Applications accepted using PhORCAS and the NMS. No person at this residency will solicit, accept, or use any ranking-related information from any residency applicant.

Application deadline is December 27, 2021 and residency start date is mid-June and ends on June 30 of the following year.

Please visit our website for additional information at: TBD